Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening

摘要

BackgroundMalignancy risks in patients with neurofibromatosis 1 (NF1) are increased, but those occurring outside of the nervous system have not been clearly defined.